Document is current
Any future updates will be listed below
-
Authors
Kleinbongard, Petra https://orcid.org/0000-0003-3576-3772
Arriola, Carlos Galán https://orcid.org/0000-0001-7403-8974
Badimon, Lina https://orcid.org/0000-0002-9162-2459
Crisostomo, Veronica https://orcid.org/0000-0003-1740-7029
Giricz, Zoltán https://orcid.org/0000-0003-2036-8665
Gyöngyösi, Mariann https://orcid.org/0000-0002-7083-2107
Heusch, Gerd https://orcid.org/0000-0001-7078-4160
Ibanez, Borja https://orcid.org/0000-0002-5036-254X
Kiss, Attila https://orcid.org/0000-0003-4652-1998
de Kleijn, Dominique P. V. https://orcid.org/0000-0003-2714-2140
Podesser, Bruno K. https://orcid.org/0000-0002-4641-7202
Carracedo, Rafael Ramírez https://orcid.org/0000-0002-8391-2245
Rodríguez-Sinovas, Antonio https://orcid.org/0000-0003-2930-8773
Ruiz-Meana, Marisol https://orcid.org/0000-0002-4067-4638
Sanchez Margallo, Francisco M. https://orcid.org/0000-0003-2138-988X
Vilahur, Gemma https://orcid.org/0000-0002-2828-8873
Zamorano, José Luis https://orcid.org/0000-0002-0487-1749
Zaragoza, Carlos https://orcid.org/0000-0002-1706-8592
Ferdinandy, Peter https://orcid.org/0000-0002-6424-6806
Hausenloy, Derek J. https://orcid.org/0000-0003-0729-4956
-
Funding
Funding for this research was provided by:
Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033)
Duke-NUS Signature Research Programme (Singapore Translational Research Investigator Award (MOH-STaR21jun-0003)MOH-STaR21jun-0003, Centre Grant scheme (NMRC CG21APR1006), Collaborative Centre Grant scheme (NMRC/CG21APRC006))
Ministry for Innovation and Technology in Hungary (2020-1.1.5-GYORSÍTÓSÁV-2021-00011, RRF-2.3.1-21-2022-00003 "National Heart Laboratory, Hungary")
Hungarian National Scientific Research Fund (OTKA-138223)
Instituto de Salud Carlos III (ISCIII, grant PI20/0247)
Centro Nacional de Investigaciones Cardiovasculares (-)
Ministerio de Ciencia e Innovación (-)
Pro CNIC Foundation (-)
Deutsche Forschungsgemeinschaft (CRC 1116 B8, RTG 2989, CRC 1116 B8, RTG 2989)
European Union COST Action METAHEART (CA 22169, CA 22169)
Ludwig Boltzmann Gesellschaft (CARREM, CARREM)
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Received: 29 May 2024
Revised: 27 August 2024
Accepted: 27 August 2024
First Online: 18 October 2024
Change Date: 27 October 2024
Change Type: Update
Change Details: Author names of Petra Kleinbongard, Carlos Galán Arriola, Lina Badimon, Veronica Crisostomo, Zoltán Giricz, Mariann Gyöngyösi were mentioned twice in author line.
Declarations
:
: P.F. is the founder and CEO and ZG is involved in the management of Pharmahungary Group, a group of R&D companies. Pharmahungary Group has a conflict of interest as it may be organizing multicenter studies on cardioprotection on external request and potentially including the here validated sites of the current COST action (IG16225). D.J.H. has received: consultant fees from Faraday Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH; honoraria from Servier; and research funding from Astra Zeneca, Merck Sharp & Dohme Corp and Novonordisk. J. L. Z. received speaker honoraria from Pfizer, Bayer, Novartis, and Amgem. All other authors declare no competing interests.
: The experimental protocols conformed to the EU directive 2010/63EU on the protection of animals used for scientific purposes and the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines []. The experimental protocols were formally approved by the appropriate national or institutional ethics committees (see Suppl. Data sheet experimental design).
